Antimicrobial guidelines in clinical practice: incorporating the ethical perspective

Area of Science:

• Medical Ethics
• Infectious Diseases
• Health Policy

Background:

• Antimicrobial therapy guidelines require regular updates due to evolving resistance patterns and scientific knowledge.
• Shifting to broader-spectrum antibiotics impacts individual patient outcomes (efficacy, toxicity) and population-level concerns (resistance, cost).
• A structured approach is needed to navigate complex antibiotic policy decisions.

Purpose of the Study:

• To develop a comprehensive framework for addressing antibiotic policy dilemmas.
• To integrate clinical data evaluation with ethical analysis for informed decision-making.
• To guide the revision of antimicrobial therapy guidelines.

Main Methods:

• A preliminary decision-making framework was developed from literature and expert discussions.
• The framework was refined by incorporating specific antibiotic policy themes.
• The adapted framework's completeness and utility were assessed in moral deliberation groups using statistical software.

Main Results:

• The final framework details a three-phase process: factual data exploration, ethical deliberation and policy formulation, and feasibility assessment.
• Decisions are informed by considering the individual patient, the patient population, and societal implications.
• The framework structures data evaluation, identifies knowledge gaps, and explicates ethical considerations.

Conclusions:

• The proposed framework aids antibiotic policy decisions by organizing data and highlighting ethical factors.
• It facilitates balancing the interests of individual patients with those of current and future generations.
• This structured approach supports the responsible revision of antimicrobial stewardship policies.